6-alkylamino- and 2,3-dihydro-3′-methoxy-2-phenyl-4-quinazolinones and related compounds:: Their synthesis, cytotoxicity, and inhibition of tubulin polymerization

被引:427
作者
Hour, MJ
Huang, LJ
Kuo, SC
Xia, Y
Bastow, K
Nakanishi, Y
Hamel, E
Lee, KH [1 ]
机构
[1] China Med Coll, Grad Inst Pharmaceut Chem, Taichung, Taiwan
[2] Univ N Carolina, Sch Pharm, Div Med Chem & Nat Prod, Chapel Hill, NC 27599 USA
[3] NCI, Frederick Canc Res & Dev Ctr, Div Canc Treatment & Diag, Dev Therapeut Program,Screening Technol Branch, Frederick, MD 21702 USA
关键词
D O I
10.1021/jm000151c
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
As part of our continuing search for potential anticancer candidates among 2-phenyl-4-quinolones and 2-phenyl-4-quinazolinones, two series of 6,7,2',3',4',5'-substituted 2-phenyl-4-quinazolinones and 6,2',3',4',5'-substituted 2,3-dihydro-2-phenyl-4-quinazolinones were synthesized and evaluated for cytotoxicity and as inhibitors of tubulin polymerization. In general, a good correlation was found between the two activities. Five of the 6-substituted heterocyclic 2-phenyl-4-quinozolinones (37-51) showed significant cytotoxicity against a panel of human tumor cell lines with EC50 values in the low micromolar to nanomolar concentration ranges. Compound 38 was the most potent of these compounds, as well as the most potent inhibitor of tubulin polymerization in this series. The activity of 38 was in the same range as those of the antimitotic natural products, colchicine, podophyllotoxin, and combretastatin A-4. Substituted 2-phenyl-4-quinazolinones and 2,3-dihydro-2-phenyl-4-quinazolinones also displayed highly selective cytotoxicity against the ovarian cancer 1A9 and P-gp resistant KB-VIN cell lines.
引用
收藏
页码:4479 / 4487
页数:9
相关论文
共 22 条
[11]   ANTITUMOR AGENTS .150. 2',3',4',5',5,6,7-SUBSTITUTED 2-PHENYL-4-QUINOLONES AND RELATED-COMPOUNDS - THEIR SYNTHESIS, CYTOTOXICITY, AND INHIBITION OF TUBULIN POLYMERIZATION [J].
LI, L ;
WANG, HK ;
KUO, SC ;
WU, TS ;
LEDNICER, D ;
LIN, CM ;
HAMEL, E ;
LEE, KH .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (08) :1126-1135
[12]   ANTITUMOR AGENTS .155. SYNTHESIS AND BIOLOGICAL EVALUATION OF 3',6,7-SUBSTITUTED 2-PHENYL-4-QUINOLONES AS ANTIMICROTUBULE AGENTS [J].
LI, LP ;
WANG, HK ;
KUO, SC ;
WU, TS ;
MAUGER, A ;
LIN, CM ;
HAMEL, E ;
LEE, KH .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (20) :3400-3407
[13]  
LIN CM, 1991, MOL PHARMACOL, V40, P827
[14]   FEASIBILITY OF A HIGH-FLUX ANTICANCER DRUG SCREEN USING A DIVERSE PANEL OF CULTURED HUMAN TUMOR-CELL LINES [J].
MONKS, A ;
SCUDIERO, D ;
SKEHAN, P ;
SHOEMAKER, R ;
PAULL, K ;
VISTICA, D ;
HOSE, C ;
LANGLEY, J ;
CRONISE, P ;
VAIGROWOLFF, A ;
GRAYGOODRICH, M ;
CAMPBELL, H ;
MAYO, J ;
BOYD, M .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (11) :757-766
[15]  
NEIL GL, 1972, CANCER CHEMOTH REP 1, V56, P163
[16]   THE CLINICAL-PHARMACOLOGY AND USE OF ANTIMICROTUBULE AGENTS IN CANCER CHEMOTHERAPEUTICS [J].
ROWINSKY, EK ;
DONEHOWER, RC .
PHARMACOLOGY & THERAPEUTICS, 1991, 52 (01) :35-84
[17]   Structure-activity analysis of the interaction of curacin A, the potent colchicine site antimitotic agent, with tubulin and effects of analogs on the growth of MCF-7 breast cancer cells [J].
Verdier-Pinard, P ;
Lai, JY ;
Yoo, HD ;
Yu, JR ;
Marquez, B ;
Nagle, DG ;
Nambu, M ;
White, JD ;
Falck, JR ;
Gerwick, WH ;
Day, BW ;
Hamel, E .
MOLECULAR PHARMACOLOGY, 1998, 53 (01) :62-76
[18]   PACLITAXEL (TAXOL(TM)) AND DOCETAXEL (TAXOTERE(TM)) - NOT SIMPLY 2 OF A KIND [J].
VERWEIJ, J ;
CLAVEL, M ;
CHEVALIER, B .
ANNALS OF ONCOLOGY, 1994, 5 (06) :495-505
[19]  
Xia Y, 1999, CURR MED CHEM, V6, P179
[20]   Antitumor agents.: 181.: Synthesis and biological evaluation of 6,7,2′,3′,4′-substituted-1,2,3,4-tetrahydro-2-phenyl-4-quinolones as a new class of antimitotic antitumor agents [J].
Xia, Y ;
Yang, ZY ;
Xia, P ;
Bastow, KF ;
Tachibana, Y ;
Kuo, SC ;
Hamel, E ;
Hackl, T ;
Lee, KH .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (07) :1155-1162